College of DuPage Nursing Alumna Awarded Schweitzer Fellowship to Educate Chicago's Polish Community on Preventative Care in Reproductive Health
June 25, 2020 14:50 ET | College of DuPage
Glen Ellyn, Ill., June 25, 2020 (GLOBE NEWSWIRE) -- College of DuPage 2019 Nursing alumna Julia Walczak recently was awarded the prestigious Albert Schweitzer Fellowship for her proposal to initiate...
2019 logo_150x35_jpg.jpg
Novan Receives Phase 2 NIH Federal Grant of Approximately $1.0 Million
February 20, 2020 08:15 ET | Novan, Inc.
Provides funds to evaluate the mechanistic antiviral activity of WH602Novan to progress IND-enabling toxicology and pharmacology studies for WH602 Grant is additive to $223,000 Phase 1 NIH grant...
Actor Ernie Hudson to serve as national spokesperson for Think About the Link
December 16, 2019 12:48 ET | Prevent Cancer Foundation
Alexandria, Va., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Ernie Hudson is best known for his role in the 1984 cult classic, Ghostbusters; however few fans know him as two-time cancer survivor. Hudson was...
Innovation Pharmaceuticals:  Oral Cancer on the Rise; Company Offers Perspectives on Opportunity of Brilacidin for the Prevention of Oral Mucositis
November 13, 2019 08:30 ET | Innovation Pharmaceuticals, Inc.
Oral cancer incidence increasing worldwide due to spread of human papillomavirus (HPV), Oral SexMillions of patients worldwide suffer from treatment-induced Oral Mucositis (OM)Existing OM therapies...
2019 logo_150x35_jpg.jpg
Novan Awarded Approximately $1.1 Million Grant by Department of Defense
September 20, 2019 08:30 ET | Novan, Inc.
Funds to progress women’s health product candidate, WH504Additive to recently announced NIH grant for WH602Women’s health initiative to focus on potential HPV related onco-virus therapeutics ...
OmniPathology Validates New Genetic Test for Early Detection of HPV-Related Cancer
August 06, 2019 08:45 ET | OmniPathology
PASADENA, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- OmniPathology (, a physician-owned medical laboratory specializing in state-of-the-art pathology services, today announced...
novan logo.jpg
Novan’s Drug Substance Demonstrates Inhibition of HPV-18 Virus Production
July 24, 2019 08:30 ET | Novan, Inc.
Preclinical data published in Antiviral ResearchStudy conducted by Drs. N.S. Banerjee, L.T. Chow and T.R. Broker at The University of Alabama at BirminghamFindings reinforce anti-viral mechanism of...
novan logo.jpg
Novan Publication Supports Women’s Health Business Unit Initiative and Nitric Oxide’s Potential Against HPV-Associated Diseases
November 01, 2018 08:05 ET | Novan, Inc.
Data from SB206 Phase 2 clinical trial in external genital warts have been published in the Journal of Drugs in DermatologySB206 was efficacious and well tolerated in the trialAdvancement of the late...
novan logo.jpg
Novan Creates Dedicated Women’s Health Business Unit
October 25, 2018 07:05 ET | Novan, Inc.
Business unit will focus on Novan’s proprietary nitric oxide technology and its application to target high-risk human papillomavirus (HPV) and associated cancers affecting women such as cervical...
novan logo.jpg
Novan Expands Nitric Oxide Dermatology Business Partnership with Sato in Japan
October 08, 2018 08:00 ET | Novan, Inc.
Expanded license agreement adds SB206 for the treatment of viral skin infections Novan to receive upfront cash consideration of approximately 1.25 billion JPY (~$11.0 million), payable over the next...